Truist lowered the firm’s price target on Teleflex (TFX) to $200 from $227 and keeps a Hold rating on the shares as part of a broader research note previewing 2025 in Medical Technology. The firm sees ...
TFX boasts a Value Style Score of B and VGM Score of B, and holds a Zacks Rank #3 (Hold) rating. Shares of Teleflex are trading at a forward earnings multiple of 13.9X, as well as a PEG Ratio of 2 ...